that's where we come in at benchling.n a greater need. here with this software? just to paint a picture, creating a medicine is harder and even then, most medicines still fail when they're tested in patients. to help those scientists organise their experiments�* data analysis all in one place, and then feed that straight helped solve. absolutely. r&d organisations in the world. of big pharma companies like sanofi or moderna. to market that we've helped support from a technology perspective, everything from the monoclonal antibodies re—engineering a patient�*s immune system with things so the first cell therapies for, you know, leukaemias and other blood cancers. in the market. advantage right now? where is it that that successful r&d is being done, and, one would assume, where you're focusing your attention? in biomedical research and innovation and creating, but actually china has been a hot topic um, and it's definitely lit a fire. so china has their made in 2025 plan where they sort of made it a national priority to be